Russia has confirmed 2 322 056 cases of coronavirus and 40 464 deaths. For December 01, the authorities confirmed 26 402 new coronavirus cases and a new record of 569 coronavirus deaths.
- Universities in Moscow and St. Petersburg will switch students to remote learning until early February to prevent the spread of coronavirus.
— Russia's Vector Institute is preparing to publish the results of a clinical trial of Russia's second coronavirus vaccine. Called "EpiVacCorona", the vaccine is expected to enter civilian circulation in early December.
— Russia's military has launched a coronavirus vaccine campaign among nearly half a million of its active-duty personnel. Up to 80 000 Russian soldiers are expected to receive Russia's vaccine by the end of the year.
— Indian pharmaceutical company Hetero will produce 100 million doses of Russia's Sputnik V coronavirus vaccine as part of the agreement with the Russian Direct Investment Fund (RDIF).
— Moscow has further extended measures aimed at slowing the spread of the coronavirus until Jan. 15, Mayor Sergei Sobyanin announced Thursday. The measures include a self-isolation order for residents aged 65 and older and the requirement for 30% of all businesses' employees to work remotely.
— Moscow reported a 300% month-on-month increase in coronavirus deaths for October, the Russian capital’s health department announced late Thursday. Coronavirus was the main cause in 2 235 deaths reported that month.
— Russia will start its mass vaccination campaign against the coronavirus in 2021, Deputy Prime Minister Tatyana Golikova said. Developers plan to produce 2 million doses of the Russian Sputnik V coronavirus vaccine by the end of this year.
— Russia's Sputnik V coronavirus vaccine is 95% effective, its developers said Tuesday. The calculations were based on preliminary data obtained 42 days after volunteers received the first dose, the Health Ministry, the state-run Gamaleya research center and the Russian Direct Investment Fund (RDIF) said in a joint statement.